NCT02605642 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade Status COMPLETED Phase N/A
NCT02598739 Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic Arthritis Status COMPLETED Phase NA
NCT02584855 A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02572700 Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis Status UNKNOWN Phase N/A
NCT02558361 Treatment With Apremilast in Patients With Psoriatic Arthritis Status WITHDRAWN Phase PHASE4
NCT02556034 Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA. Status COMPLETED Phase N/A
NCT02538341 Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Status COMPLETED Phase PHASE2
NCT02530268 The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry Status ENROLLING_BY_INVITATION Phase N/A
NCT02486302 A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. Status COMPLETED Phase N/A
NCT02475304 Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis Status WITHDRAWN Phase PHASE2
NCT02472717 Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study Status WITHDRAWN Phase PHASE2
NCT02470481 A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics Status COMPLETED Phase N/A
NCT02429895 A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 Status TERMINATED Phase PHASE2
NCT02414633 Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI]) Status COMPLETED Phase N/A
NCT02413749 DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA Status COMPLETED Phase N/A
NCT02404350 Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02376790 Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis Status COMPLETED Phase PHASE3